http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : Duy-Viet Vo (검색결과 1 건)
-
Duy-Viet Vo Kangwon National University 2020 국내석사
Design, Synthesis and Structure-Activity Relationship Studies of Bioactive Ligands with Heterocyclic Scaffolds Duy-Viet Vo Department of Pharmacy Graduate School, Kangwon National University Abstract SECTION 1 Drug Development with Flavonol Scaffold as Chemotherapy-induced Peripheral Neuropathy (CIPN) Modulators Currently, no sufficient treatment options are available for treatment CIPN; hence it is essential to find other safe and effective treatments. Natural products such as plant secondary metabolites are still important molecules of interest in the treatment of various pain conditions. The known in vitro and in vivo studies of CIPN therapeutics have shown flavonoids as the promising agents for the treatment of CIPN. The present research will focus on investigating the flavonoids, mainly flavonols, flavonol analogues and their derivatives with effects on CIPN. We succeeded to design, synthesize a series of galangin analogues and their derivatives and evaluate their bioactivity against CIPN. We effectively developed a new method to synthesize the flavonol analogues via the nucleophilic substitution of the α-bromide compound and the Baker-Venkataraman rearrangement as key reactions with overall 6-8 steps and effective with high yield (~ 10%) from commercially available chemicals. In our efforts to discover pharmacologically superior analgesic effects for the treatment of CIPN, we operated an approach to design the structure requirements for activity on CIPN. From the present SAR studies that we have the preliminary conclusions for the analgesic effect of flavonol’s for treatment CIPN. The result of this study will be helpful to amplify and comprehend the development of flavonols analgesic effects on CIPN. Keywords: flavonol, galangin analogues, galangin derivaties, thioketones, nucleophilic substitution of α-ketone, Baker-Venkataraman rearrangement, analgesic effect, CIPN, SAR study, drug design. SECTION 2 Drug Development with 1,3,5-Triazine Scaffolds as GPR119 Agonists GPR119 is a G protein-coupled receptor (GPCR) expressed both in pancreatic β cells and enteroendocrine L cells. In vitro and in vivo studies show that GPR119 agonists can improve glucose homeostasis, proving GPR119 is a promising target for the treatment of type 2 diabetes. For the drug development study on GPR119, compound AR-231453 was chosen as the hit structure. The replacement of the 5-nitropyrimidine with less hepatotoxicity 1,3,5-triazine in parent rings was performed and assessed for their biological activity. Then two anilinos substituted by electron-withdrawing groups (EWG) were provided as tail moiety linked to the novel scaffold. Finally, replacement of the piperidine ring with conformationally controlled azabicyclic rings constructed a new series of 1,3,5-triazine analogues 2a-2l. We assessed the introduction of inflexible fragments like azabicyclic moieties to the ligands that decreased the conformational suppleness to create an ideal conformation and best recognized by the receptor. We have also investigated synthetic pathway as a novel and stereoselective method of a series of key intermediate azabicyclic alcohols or amines 3a-3f in the good to excellent yields. In the synthetic strategy, dechlorination reaction with H2 and TEA, using 10% Pd/C as a catalyst in Et2O:THF to afford the target compounds 2a-2l was also studied as the key reaction. Nevertheless, the yield of the dechlorination reaction was not agreeable. Hence, the optimal conditions will be researched in subsequent studies to support the discovery of the lead compounds on 1,3,5-triazine scaffold for GPR119 agonist activity. Keywords: GPR119 agonist, type 2 diabetes, 1,3,5-triazine, stereoselective of azabicyclic alcohols and amines, dechlorination, drug design.
연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
